Service provider Saltigo is reinforcing its position in the
stabilising fine chemical custom manufacturing industry by
investing in the expansion of its German facility.
Firms engaging in both in-house and contract pharma manufacturing
generally display inferior performance compared to manufacturers
conducting only in-house production, according to new research.
Sigma-Aldrich Group member SAFC made its presence felt at the
recent CPhI in Paris with announcements regarding its expansion
activities in transgenic manufacturing and India.
Pfizer CentreSource has decided to outsource the manufacture of some of its active pharmaceutical ingredients (API) to two Asian contract manufacturers and intends to work with the Food and Drug Administration's (FDA) during the process.
Cardinal Health says it is experiencing a "robust market" for its
cell line engineering technology, as it attracts the attention of
pharma giant Wyeth and executes capacity expansion plans its for
full service offerings...
Indian biopharmaceutical company Wockhardt has signed a deal with
Maharashtra Industrial Development Corporation (MIDC) to establish
a special economic zone (SEZ) in Aurangabad, India, in order to
expand its manufacturing capabilities.
Following numerous manufacturing failures, Discovery Laboratories
believes it has resolved the stability issues that have plagued
Surfaxin, its experimental respiratory treatment for infants, and
is now seeking a meeting with the...
A majority stake in Irish biotechnology contract services firm
Archport has been snapped up by German-based Chemie Uetikon as the
bio-outsourcing market heats up.
Drug developing services provider Aptuit has acquired the
pharmaceutical services division of technology firm EaglePicher,
enriching its active pharmaceutical ingredient (API) and drug
substance manufacturing offerings.
US contract pharmaceutical manufacturer Metrics has announced a
$17.5m (€13.7m) investment to double the size of its drug testing
and manufacturing plant over the next three years.
Chemir Analytical Services, the new owner of Gateway Chemical
Technology, has renamed the custom chemical analysis business
IQsynthesis in a revamp effort.
Cardinal Health has been given the green light from the US Food and
Drug Administration (FDA) to start manufacturing the first
commercial drug at its new sterile facility in North Carolina.
Kemwell has sealed the deal on the purchase of Pfizer's Swedish
manufacturing plant and at the same time secured a long-term
contract manufacturing agreement with the drug giant.
Successful technology transfer and effective management can help
avoid disappointment with contract manufacturing arrangements,
which often fail to live up to pharmaceutical company expectations.
A good selection process, with a realistic set of selection
criteria is essential when looking for the right contract
manufacturing partner, according to a new Datamonitor report.
Offshoring contract manufacturing is not the only option for large
pharma firms looking to drive productivity and efficiency gains in
drug manufacturing, warns a new report from independent market
analyst Datamonitor.
Dalton Pharma Services has introduced a range of new medicinal
chemistry services that are available to companies involved in drug
discovery that wish to utilise additional scientific and managerial
expertise as well as specialised...
After selling a manufacturing plant in Texas to Cardinal Health two
years ago, Adams Respiratory Therapeutics has reacquired the
facility in order to produce its expectorant Mucinex (guaifenesin
extended-release), responding to a...
In the first drug master file (DMF) approval of its kind, the US
Food and Drug Administration (FDA) has approved the sale of
metformin hydrochloride tablets which are produced by an Indian
company using a pharmaceutical formulation...
Biopharmaceutical firm Altus has asked contract manufacturer Althea
to produce Phase III quantities of a crystallised formulation of
human growth hormone (hGH) which can be administered subcutaneously
weekly instead of daily.
Despite its consolidation, the competitive consumable sector still
offers potential for rapid growth and better profits in the
biopharmaceutical industry, while contract bioprocessing services
will be increasingly in demand, according...
For the first time Merck has opened the doors of its
under-construction manufacturing plant in North Carolina to public
officials, boasting it will eventually contribute about two-thirds
of its annual live-virus vaccine production.
Pennsylvania environmental regulators have accused Merck of
hampering their investigation of a chemical discharge from its West
Point facility that resulted in a major fish kill on the local
creek and threatened the water supplies...
India's potential to further boost its already dominant role in
global generics production, as well as an offshore location of
choice for contract manufacturing, presents an opportunity worth an
estimated $48bn (€38bn) in 2007,...
More problems at Patheon's Puerto Rican production facilities in
the third quarter of 2006 are expected to reduce the contract
manufacturer's earnings before interest, tax, depreciation and
amortisation (EBITDA) by more...
While Lonza's biopharmaceutical business has taken off, tough
competition from cheap Asian competitors is eating away at its
exclusive synthesis business - meanwhile, the whole business is
being hit by rising raw material and...
Cambrex's Q2 results show that the life sciences firm is slowly
making a comeback after being crushed by a $140.3m (€116.7m) loss
in Q4, however, it has failed to completely stem the bleed from its
Biopharma unit, blamed for...
Most pharmaceutical companies know little about how to make
biopharmaceuticals on a large scale and so they need to develop
in-house expertise as well as outsource several steps in their
production chain, advises the head of chemistry...
Israeli biopharma firm Kamada will manufacture transferrin for an
undisclosed European pharma firm embarking on the first ever
clinical trials of a drug that includes the substance.
The Japanese pharmaceutical industry is eyeing India as a new hub
to conduct its contract manufacturing and clinical trials - India
is thirsty for new Japanese investment.
Active pharmaceutical ingredient (API) manufacturers in Europe are
struggling to differentiate their capabilities and compete in an
outsourcing market suffering from overcapacity, diminishing
profitability and threats from Asia.
SR Pharma has recruited Genzyme, BioSpring and OctoPlus to
formulate and manufacture its lead RNAi therapeutic product Atu027
to good manufacturing practice (GMP) standards, as its liposomal
drug delivry system moves forward.
Frost & Sullivan has awarded biopharmaceutical firm Cytogenix
with its 2006 award for innovation in biotechnology processing for
its cell-free manufacturing method that enables generation of large
quantities of high-purity DNA...
India's Dishman Pharmaceuticals & Chemicals has snapped up the
Swiss-based pharmaceutical services business, Carbogen and Amcis,
of financially-troubled US chemical firm Solutia for the sum of
$74.5m (€58m).
Cardinal Health has taken the contract manufacturing crown after
being honoured with a prestigious award from Frost & Sullivan
in recognition of its ability to provide biopharma firms with a
high quality service, while still remaining...
Cardinal Health has implemented a series of business reshuffles and
cost cutting measures in the hope of pulling itself out of poor
profitability after disappointing third quarter results.
US-based Nabi Biopharmaceuticals has secured an exclusive supply
and contract manufacturing deal with French-based vaccines giant
Sanofi Pasteur to streamline the production of its rabies vaccine.
American Peptide Company (APC) has entered into a manufacturing
agreement with Affymax for the clinical supply of the first in its
pipeline of peptide-based drugs.
Laureate Pharma, a full service biopharmaceutical development and
protein production company, has been given a new contract by
Bradmer Pharmaceuticals to develop and manufacture its novel brain
cancer treatment for Phase III clinical...
Cambrex Bio Science has been given a contract to manufacture
Geron's GRNVAC1 telomerase vaccine for use in clinical trials and
will now transfer production to its Walkersville, Maryland
facility.
Dragon Pharmaceutical has bowed out of a development and
manufacturing contract with Austria's Polymun Scientific, selling
it instead to Swiss company AS Biotech for $1m.
Having inked two new deals with large Indian contract research
organisations (CROs), US generics major Taro Pharmaceutical
Industries is beginning to shift some of its product R&D to
India in a bid to enhance its competitive position...
Oman Pharmaceutical Products (OPP) has entered its first
outsourcing partnership in Europe with Finnish company
Dragenopharm, providing the first step in its strategy to offer
contract manufacturing services globally.
Indena offers custom development by leveraging the expertise of a specialized team devoted to designing and developing processes and analytical methods....
